Bempedoic Acid Therapy for Polycystic Kidney Disease
Bempedoic Acid Therapy for Polycystic Kidney Disease
Recruiting · NCT07282821 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bempedoic Acid Therapy for Polycystic Kidney Disease | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07282821 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tufts University Medical Center | Boston | United States | 3 |
| University of Maryland, Baltimore | Baltimore | United States | 32 |
| University of Vermont Medical Center | Burlington | United States | 157 |